Safety and efficacy of sofosbuvir/velpatasvir in a genotype 1-3 HCV infected russian and swedish population: Results from a phase 3, prospective trial

Authors
Category Primary study
JournalHepatology
Year 2017
This article has no abstract
Epistemonikos ID: 7f0c67ba9ebe8f322b49b419c5981753412658ff
First added on: Feb 08, 2025